• Health

    Natco Pharma’s Kothur unit classified as ‘voluntary action indicated’ by US regulator

    AnyFans Posted on

    By Ctionsnatco Pharma

    Copyright indiatimes

    Natco Pharma's Kothur unit classified as 'voluntary action indicated' by US regulator

    ETMarkets.comRepresentative image.

    Natco Pharma Ltd on Thursday said it has received an establishment inspection report from the US health regulator for its Kothur unit in Hyderabad, classifying the facility as ‘voluntary action indicated’. The US Food and Drug Administration (FDA) had conducted an inspection at the company’s pharma division located in Kothur, Hyderabad, Natco Pharma said in a regulatory filing. The unit has now received Establishment Inspection Report (EIR) classifying the facility as “Voluntary Action Indicated (VAI)”, it added.Add as a Reliable and Trusted News Source Add Now!
    Under voluntary action indicated (VAI), while objectionable conditions were found and documented during an inspection, the agency is not prepared to take or recommend regulatory action, as per the USFDA.(You can now subscribe to our Economic Times WhatsApp channel)

    Read More News onNatco PharmaKothur unitUSFDANew Delhiestablishment inspection reportUS Food and Drug AdministrationNatco Pharma Ltdkothurnatco pharma ltd

    (Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online….moreless

    (You can now subscribe to our Economic Times WhatsApp channel)Read More News onNatco PharmaKothur unitUSFDANew Delhiestablishment inspection reportUS Food and Drug AdministrationNatco Pharma Ltdkothurnatco pharma ltd(Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online….moreless

    You Might Also Like